Add BrightSurf on Google Email

NIH-funded study sheds light on abnormal neural function in rare genetic disorder

A NIH-funded study identified neuronal abnormalities in cortical cells from individuals with 22q11.2 deletion syndrome, a genetic disorder associated with mental illnesses and developmental delays. The study suggests that overexpression of the DGCR8 gene and exposure to certain antipsychotic drugs can restore normal cellular functioning.

SourceNIH/National Institute of Mental Health·JournalNature Medicine·DateSep 28, 2020

Progress toward a treatment for Krabbe disease

A study by University of Pennsylvania researchers describes an effective gene therapy for Krabbe disease in dogs, which has shown promising results with no significant symptoms after four years. The treatment approach, using the AAV9 vector, has also been found to positively affect both central and peripheral nervous systems.

SourceUniversity of Pennsylvania·JournalJournal of Clinical Investigation·DateAug 26, 2020

Your in-laws' history of drinking problems could lead to alcohol issues of your own

A recent study published in Psychological Science found that marriage to a spouse with a history of parental alcohol misuse increases the likelihood of developing alcohol use disorder. The research suggests that it's not the spouse's genetic makeup but rather their upbringing by an AUD-affected parent that influences this risk.

SourceAssociation for Psychological Science·JournalPsychological Science·DateAug 20, 2020

RNA as a future cure for hereditary diseases

Researchers at ETH Zurich have developed RNA molecules that can compensate for gene mutations in bone marrow cells, a potential breakthrough for treating rare hereditary diseases. The molecules bind to the body's own RNA and restore ferrochelatase enzyme production, which is deficient in patients with erythropoietic protoporphyria.

SourceETH Zurich·JournalNucleic Acids Research·DateAug 18, 2020

Epigenetic risk for PTSD in trauma survivors

Researchers studied epigenetic modifications associated with posttraumatic stress disorder (PTSD) in trauma survivors, finding a link to the gene NTRK2 and reduced PTSD risk. The study revealed that epigenetic modification of NTRK2 was predictive of PTSD risk, but its relationship with PTSD is complex and influenced by multiple factors.

SourceProceedings of the National Academy of Sciences·JournalProceedings of the National Academy of Sciences·DateAug 17, 2020

Rosalind Franklin University Researcher awarded NIH grant for CLN3 Batten disease study

A new therapeutic approach for CLN3 Batten disease has been developed by a team led by Rosalind Franklin University researcher Michelle Hastings. The treatment uses antisense oligonucleotides to target the mutated gene causing the disease, showing promise in rodent models and human cells cultured from patients.

Genes affecting brains and brawn?

A new study by Penn State researchers reveals that genetic deletions linked to neurodevelopmental disorders affect not only brain development but also other parts of the body. The findings suggest that these deletions can cause defects in multiple organ systems, including heart, kidney, and skeletal structures.

SourcePenn State·JournalPLOS Genetics·DateJun 24, 2020

New research suggests in-womb gene correction

Researchers at Oregon Health & Science University developed a synthetic molecule that targets and corrects a mutated gene causing Usher syndrome in mice. The technique may be used to deliver drug therapy through amniotic fluid to the fetus, potentially treating and preventing several types of congenital hearing and balance disorders.

SourceOregon Health & Science University·JournalNucleic Acids Research·DateApr 5, 2020

Advancing gene therapies: PIP pip hurray!

Researchers at Kyoto University have designed a new compound that can bind to DNA and activate genes, which could lead to new treatments for cancers and hereditary diseases. The compound, called ePIP-HoGu, targets specific DNA sequences and recruits gene-modifying molecules.

SourceKyoto University·JournalChemical Communications·DateFeb 28, 2020

A new model of the worm C. elegans to progress in the study of a rare disease

A new model of chromosome X-linked adrenoleukodystrophy in C. elegans has been identified, accelerating research on the disease and its potential pharmacological targets. The model points to glial cells as responsible for neurological damage, with oxidative stress caused by mitochondria being a major cause.

SourceIDIBELL-Bellvitge Biomedical Research Institute·JournalFree Radical Biology and Medicine·DateFeb 19, 2020

Missing link in rare inherited skin disease exposed

Hokkaido University scientists have discovered the missing link in a rare hereditary disease that impairs the skin's barrier function. They found that fatty acid transporter member 4 (FATP4) plays a critical role in synthesizing acylceramides, key skin lipids that prevent water loss and protect against pathogens.

SourceHokkaido University·JournalProceedings of the National Academy of Sciences·DateJan 29, 2020

30-year study identifies need of disease-modifying therapies for maple syrup urine disease

A 30-year study details clinical course of 184 individuals with genetically diverse forms of MSUD, showing increased survival and hospitalization rates. Despite advances in care, patients continue to suffer from cognitive and psychiatric disabilities, highlighting the need for safer and more effective disease-modifying interventions.

SourceClinic for Special Children·JournalMolecular Genetics and Metabolism·DateJan 24, 2020